February, 2025

article thumbnail

AI-Powered Pharma: How Artificial Intelligence is Transforming Drug Development,

Pharma IQ

Discover how AI is transforming pharmaceutical development, from drug discovery to clinical trials, supply chain resilience, and personalised medicine.

Pharma 130
article thumbnail

The Nurse as Designer: Breaking Down Barriers with Clinician-Center Innovation

MedCity News

Integrating nursing expertise into technology design, development, and implementation fosters early user support, establishes credibility with the technology, and leads to significantly better usage across the organization, avoiding the creation of process workarounds. The post The Nurse as Designer: Breaking Down Barriers with Clinician-Center Innovation appeared first on MedCity News.

Leads 164
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Beyond Pills: How Pharma is Embracing Diversity, AI, and Compassionate Care

Pharma Leaders

The pharmaceutical industry is in a period of rapid transformation. Driven by innovation and evolving patient needs, companies face challenges balancing competitiveness, regulatory hurdles, R&D improvements, and diversity initiatives. Three key trends define this era: 1. Diversity in Clinical Trials: A Core Priority Diversity in trials is shifting from compliance to a core design element.

Pharma 52
article thumbnail

Programmatic Advertising Trends: Key Insights for Pharma Marketing Teams in 2025

Pharma Marketing Network

Introduction: In 2025, programmatic advertising will continue to redefine how pharmaceutical brands reach healthcare providers (HCPs) and patients. For pharma marketing teams, staying ahead of programmatic advertising trends is not just importantits essential for success. But what trends will shape the future, and how can your team leverage them to drive results?

Pharma 52
article thumbnail

State of AI in Sales & Marketing 2025

AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.

article thumbnail

How Digital Patient Intake is Revolutionizing Healthcare

Referral MD

We live in a world of instant communication and on-demand services. Yet, the healthcare experience often begins with a decidedly analog ritual: The dreaded patient intake form. While medical science advances, too many clinics still rely on cumbersome paperwork. For too long, the administrative side of healthcare has lagged behind its clinical advancements.

article thumbnail

Novartis nets potential first-in-class medicine in new cardiovascular acquisition

European Pharmaceutical Review

Novartis has agreed to acquire Anthos Therapeutics, Inc., and will gain rights to a potential first-in-class biologic. Anthos has been developing the monoclonal antibody abelacimab as a treatment to prevent stroke and systemic embolism in individuals with atrial fibrillation, under a license from Novartis. The therapy is designed to induce effective haemostasis-sparing anticoagulation through Factor XI inhibition, preventing the activated form (Factor XIa) being generated.

More Trending

article thumbnail

Merck Is Embracing AI, But ‘We Always Have a Human in the Loop,’ Exec Says

MedCity News

Mercks implementation of artificial intelligence in drug research includes analyzing years of existing Merck clinical data to help identify which drugs and drug combinations to pursue. But Merck executive Matt Studney said AI is tool to help, not replace humans. The post Merck Is Embracing AI, But We Always Have a Human in the Loop, Exec Says appeared first on MedCity News.

Biopharma 273
article thumbnail

Key Trends Reshaping Pharmaceutical Market Access in 2025

Pharma Leaders

In a rapidly transforming pharmaceutical landscape, securing market access remains paramount. Looking ahead in 2025, several pivotal trends are set to redefine strategies for manufacturers and industry stakeholders. 1. Digital Health: Redefining Patient Support and Engagement Digital health technologies, including AI, are fundamentally changing patient interactions and support services.

article thumbnail

Make a Difference in Rare Disease With Creativity, Data, and Innovation: Insights from Ann Cave

Eversana Intouch

In the ever-evolving landscape of pharmaceutical marketing, staying ahead of the curve is crucial. Ann Cave, president of full-service agencies at EVERSANA INTOUCH, shares invaluable insights in her article, “How Harnessing Creativity, Data and Innovation Can Help Make a Difference in a Rare Disease Patients Journey,” published in Med Ad News.

article thumbnail

Pharma Digital Marketing: Strategies to Boost Engagement and Drive ROI for Pharma Brands

Pharma Marketing Network

Introduction In todays fast-paced world, pharma digital marketing is more than just a strategyit’s a necessity. With increasing competition, strict regulations, and changing consumer behavior, pharmaceutical brands must embrace digital transformation to stay relevant. But how can pharma marketers break through the noise, engage their audience, and see real ROI?

Pharma 52
article thumbnail

The Intersection of AI and Sales: Personalization Without Compromise

Speaker: Jesse Hunter and Brynn Chadwick

Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.

article thumbnail

Could novel 3D printing method enhance intestinal drug delivery?

European Pharmaceutical Review

A study has demonstrated a new approach to prepare tablets for intestinal drug delivery by combining two 3D printing techniques. Using both selective laser sintering (SLS) and fused deposition modelling (FDM), the technique has potential to achieve delayed and prolonged drug release, according to the findings. Key findings from the 3D printing drug delivery study [a] laser speed of 90 mm s1 was suitable for producing [3D printed tablet] cores with relatively short disintegration time and suffici

article thumbnail

The Power of the Rearview: Learning from the Past to Drive Forward

Scott Burrows

In business, leadership, and life, theres a reason the windshield is bigger than the rearview mirroryour focus should always be on where youre going, not just where youve been. But that doesnt mean the past is irrelevant. In fact, the rearview mirror serves a critical purpose: it helps us learn, adjust, and make better decisions moving forward. The key is knowing how to glance back without getting stuck there.

article thumbnail

Biocompatible Nanoparticles: Tiny Antennae with Huge Potential for Brain-Computer Interfaces

MedCity News

To bridge the gap between invasive and non-invasive technologies, nanoscale materials, such as biocompatible nanoparticles, provide a promising alternative, allowing us to design materials at the scale of cellular systems and structures. The post Biocompatible Nanoparticles: Tiny Antennae with Huge Potential for Brain-Computer Interfaces appeared first on MedCity News.

273
273
article thumbnail

Pharmacists’ Role in Optimizing Outcomes for Women With Complex Health Needs

Pharmacy Times

Panelists discuss how pharmacists play a crucial role in optimizing health outcomes for women with complex health needs through comprehensive medication management, personalized consultations, and interdisciplinary collaboration. They provide targeted medication therapy, monitor drug interactions, offer medication counseling, manage chronic conditions, support reproductive health, and help patients navigate complex treatment regimens with expertise and compassionate care.

article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Rare but Prevalent: The Unequal Toll of Rare Diseases on Women

Eversana Intouch

In recent years, notable progress has been made to highlight the vast gap in womens health and boost awareness around it. On average, women spend 25% more of their lives in poor health compared to men, and closing this gap could add at least $1 trillion to annual global GDP by 2040. Fortunately, more publications and studies are also emerging to point out under-researched and under-diagnosed women-specific conditions (such as endometriosis and menopause) and conditions that disproportionally aff

article thumbnail

Choosing the Right Pharmaceutical Marketing Company: Strategies for Pharma Success

Pharma Marketing Network

Introduction: Choosing the right pharmaceutical marketing company is like picking a strategic partnerit can make or break your brands success. In todays competitive market, where digital strategies and patient-centric approaches are essential, having an expert partner is more critical than ever. But how do you know which agency is the perfect fit? With countless companies offering everything from digital advertising to HCP engagement, finding the right one can feel overwhelming.

article thumbnail

First-of-a-kind EU approval granted for oral small molecule

European Pharmaceutical Review

The European Commission has approved acoramidis as the first near complete TTR stabiliser (90 percent) to treat transthyretin amyloidosis in adults with cardiomyopathy (ATTR-CM) patients in the US and EU. BEYONTTRA (acoramidis) is indicated for adults with wild-type or variant ATTR-CM. This disease is progressively fatal and results in heart failure, BridgeBio Pharma, Inc. explained.

article thumbnail

From Gridiron to Financial Success: How to Leverage Mindset in Any Field

Scott Burrows

When you think of the qualities that make an elite athlete, you might immediately think of strength, speed, and skill. But theres something else that plays a crucial role in both sports and business: mindset. At 19, I was living my dream as a wide receiver for Florida State University and a champion kickboxer. But then, in the blink of an eye, I found myself paralyzed from the chest down after a car accident.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Bain Capital Broadens Its Biotech Reach With $3.3B Deal for Mitsubishi Tanabe Pharma

MedCity News

Bain Capitals buyout of Mitsubishi Tanabe Pharma brings a company with a drug portfolio and pipeline in areas such as immunology, central nervous system disorders, and metabolic disease. This business is the pharmaceuticals division of Japanese conglomerate Mitsubishi Chemical Group. The post Bain Capital Broadens Its Biotech Reach With $3.3B Deal for Mitsubishi Tanabe Pharma appeared first on MedCity News.

Pharma 262
article thumbnail

Why I Went From Abbot Pharma Sales to 1099 With Bruce Brown

Evolve Your Success

From navigating the halls of Abbott Laboratories and Knoll Pharmaceutical Company to pioneering his path as an independent medical device sales rep, Bruce Brown’s career journey challenges traditional sales wisdom. In this episode, he reveals the innovative strategies that helped him thrive in both worlds – including an ingenious FedEx tactic that changed his pharmaceutical sales game.

Sales 130
article thumbnail

Lessons from Training Pharmaceutical Sales Teams: Insights from the Field

Quantified

When the pandemic forced teams to shift away from in-person meetings, pharmaceutical sales training leaders had to rethink how they prepared reps for conversations with healthcare professionals. Virtual and hybrid learning models, once considered secondary to live training, quickly became essential. Now, even as in-person meetings return, companies find that a mix of formats works best.

article thumbnail

Traditional Advertising in Pharma: Proven Strategies to Boost Brand Visibility and Drive HCP Engagement

Pharma Marketing Network

Introduction In an era dominated by digital marketing, traditional advertising remains a vital tool for pharma companies to connect with healthcare professionals (HCPs) and patients alike. While online platforms grow, traditional channels such as print ads, TV commercials, and conferences continue to play a crucial role in boosting brand visibility and driving meaningful engagement.

Pharma 52
article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

Pharmaceutical training boost: how the growth and skills levy could shape industry development

European Pharmaceutical Review

The UK government has announced that the Apprenticeship Levy will be replaced by a new Growth and Skills Levy, a move designed to give employers greater control over workforce training. This change aims to address long-standing concerns that the previous system was too rigid, restricting funding primarily to apprenticeships and limiting investment in other essential training programmes.

article thumbnail

Why Vision is Key to Achieving the Impossible: My Journey to a Second Act

Scott Burrows

Sometimes life has a way of disrupting our planssometimes in ways that are so unexpected, they seem impossible to overcome. At 19, I had my entire future mapped out. I was on track to become a star in football at Florida State University, and I was already a champion black-belt kickboxer. But then, in a split second, my world was turned upside down after a devastating car accident that left me paralyzed from the chest down.

Doctors 52
article thumbnail

The Future of Training: How Virtual Reality Can Protect Clinicians from Healthcare-associated Infections

MedCity News

VR allows learners to actually see the virtual germs responsible for causing infections and spreading disease, which could otherwise only be seen under a microscope. The technology also heightens users’ senses, drawing their attention to things they would be unable to see in traditional learning environments. The post The Future of Training: How Virtual Reality Can Protect Clinicians from Healthcare-associated Infections appeared first on MedCity News.

Training 305
article thumbnail

Sales Skills You Will Need As A Medical Sales Rep With Andy Olen

Evolve Your Success

From Ted Talks to the medical sales podcast! Today’s episode has a special guest, Andy Olen. In this episode, he discusses the essential sales skills required for success as a medical sales representative. Discover Andy’s expertise as he guides high-performing individuals, executive sales leaders, and professional athletes through his coaching and training organization.

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Developing High-Impact Sales Leadership in Healthcare

Healthcare Success

This week's podcast dives into successful sales leadership and is relevant to most healthcare verticals, including B2B sales in SaaS, pharmaceuticals, medical device, hospitals, etc. It also applies to high-value B2C sales, e.g., elective surgeries, orthodontics, senior care, and residential treatment centers. My guest, Chris Jennings , CEO of Chris Jennings Group , reveals the essential traits of successful healthcare sales leadership.

Sales 65
article thumbnail

Optimizing CLL Commercial Strategies with Lab Insights

Prognos Health

Chronic Lymphocytic Leukemia (CLL) presents a complex treatment landscape. While advancements have led to new therapies, optimizing patient outcomes requires precise targeting of both healthcare providers (HCPs) and patients. Lab data, unlike claims data which offers a retrospective and often incomplete view of the patient journey, provides a real-time, granular snapshot of a patient's disease status, making it an indispensable tool for commercial pharma teams seeking to navigate this complexity

article thumbnail

Greener method for ethylene oxide manufacture identified

European Pharmaceutical Review

Scientists have developed a new, potentially safer method to produce ethylene oxide. Based on the proposed technique, adding small amounts of nickel atoms to silver catalysts can maintain production efficiency while eliminating the need for chlorine, leading to a reduced environmental impact for ethylene oxide manufacturing. What sparked this development?

article thumbnail

Impetus Digital: now offering carbon-neutral live meeting support

Impetus Digital

A year after Impetus Digital first calculated and offset all of our home office-related emissions , we’re excited to announce that we have now implemented Phase 2 of our journey toward carbon neutrality. As of January 2024, all of the carbon emissions associated with Impetus Digital staff attending hybrid meetings live (i.e., flights, ground transportation for local meetings, and accommodation) have beenand will continue to beoffset.

article thumbnail

The GTM Intelligence Era: ZoomInfo 2025 Customer Impact Report

ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!